Austin, United States
Wonderbelly, founded in 2021 and headquartered in the United States, is carving a niche in the Health Care and Pharmaceutical sectors with its unique proposition: providing “Digestive relief without compromise.” The company focuses on offering clean OTC digestive medicines that prioritize efficacy and purity.
Their product range, including Wonderbelly Antacid and Wonderbelly Multi-Symptom, utilizes the same active ingredients as leading brands, but eliminates harmful additives, offering non-GMO, vegan solutions free from dyes, sweeteners, and allergens. These products are available nationwide in top retailers like Walmart, Target, and CVS.
In April 2024, Wonderbelly secured a $12.00M Series A funding round. Esteemed investors such as AF Ventures, Elizabeth Street Ventures, and L Catterton see potential in its mission and growth trajectory. With leading pharmaceutical scientists behind its formulations, Wonderbelly is poised to disrupt the digestive health market.
